1 / 16

Drug-Receptor Interactions and Pharmacodynamics (cont.)

Drug-Receptor Interactions and Pharmacodynamics (cont.). Enzyme-linked receptors (Insulin Receptors). Dimers or multisubunits Lasts min to hrs Ex., epidermal growth factor(EGF), platelet-derived growth factor (PDGF), atrial natriuretic peptide (ANP), insulin & others.

raymondclay
Download Presentation

Drug-Receptor Interactions and Pharmacodynamics (cont.)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug-Receptor Interactions and Pharmacodynamics (cont.)

  2. Enzyme-linked receptors(Insulin Receptors) • Dimers or multisubunits • Lasts min to hrs • Ex., epidermal growth factor(EGF), platelet-derived growth factor (PDGF), atrial natriuretic peptide (ANP), insulin & others

  3. Intracellular receptors • Takes hours to days to give response • Examples: steroid H, structural pts, Es, RNA & ribosomes

  4. Characteristics of Signal Transduction • Signal Amplification e.g. albuterol • Spare receptors insulin spare Rs = 99% β-adrenoceptors = 5-10%

  5. Desensitization, & Down-Regulation of Receptors Tachyphlaxis: repeated administration of the agonist lead to decrease in responsiveness of Rs Refractory Up-regulation of receptors

  6. Dose-Response Relationships Graded dose-response curve (DRC) Potency amount of drug required to produce a given response & used to determine ED50 Candesartan 4 – 32 mg Irbisartan 75 – 300 mg Efficacy: the magnitude of response Maximal efficacy Emax

  7. Dose-Response Relationships

  8. Effect of Drug Concentration on Receptor Binding

  9. Relationship of Drug Binding to Pharmacologic Effect • Kd value used to determine affinity • The higher the Kd, the weaker the interaction, the lower the affinity • The magnitude of response is proportional to the amount of Rs bound • Emax represent full occupation of Rs • Affinity should be related to potency of drug for causing physiologic response

  10. Intrinsic activity represents the ability of a D to act as: I- Full Agonists intrin. activity =1 II- Partial Agonists intrin. activity > 0 & <1 III- Inverse Agonists Spontaneous conversion from R to R* intrin. activity < 0

  11. Effects of Partial Agonists

  12. Competitive antagonism Competitive --- Surmountable Competes with agonist in reversible fashion for same receptor site Necessary to have higher concentration of agonist to achieve same response

  13. Noncompetitive antagonism Noncompetitve --- Insurmountable Antagonist binds to a site different to that of an agonist No matter how much agonist -- antagonism cannot be overcome

  14. Antagonists I- Competitive Antagonists II- Irreversible Antagonists III- Allosteric Antagonists IV- Functional or Chemical Antagonists

  15. Therapeutic Index

More Related